Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision
Sponsor: Sun Yat-sen University
Summary
TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this population. Therefore, the investigators propose to conduct a prospective, randomized, parallel-controlled clinical trial comparing taTME with RTME for low rectal cancer, aiming to provide high-level evidence for surgical decision-making and benefit more patients.
Official title: A Prospective, Randomized, Parallel-Controlled, Superiority Clinical Study Comparing Transanal Total Mesorectal Excision (taTME) and Robot-Assisted Total Mesorectal Excision (RTME) in the Treatment of Low Rectal Cancer
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
216
Start Date
2025-06-30
Completion Date
2029-04-28
Last Updated
2026-06-16
Healthy Volunteers
No
Interventions
robotic surgery vs transanal total mesorectal excsion
This study is designed to investigate the safety and superiority of transanal total mesorectal excision (taTME) in the treatment of rectal cancer compared with robot-assisted total mesorectal excision (rTME)
Locations (1)
the sixth affiliated hospital of Sun Yat-sen University
Guangzhou, Guangdong, China